A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.

Authors:
Sassi G; Licata G; Ventriglia G; Wouters A; Lemaitre P and 13 more

Journal:
Diabetes

Publication Year: 2023

DOI:
10.2337/db22-0852

PMCID:
PMC10545562

PMID:
37494666

Journal Information

Full Title: Diabetes

Abbreviation: Diabetes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"all mouse cite-sequencing raw data and mouse gene-cell count matrices are deposited at gene expression omnibus (national center for biotechnology information) under accession number gse214031."

Code Sharing
Evidence found in paper:

"Duality of Interest. No potential conflicts of interest relevant to this article were reported."

Evidence found in paper:

"Funding. This work was supported by grants from the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek [FWO] Vlaanderen, grant G.0C63.19N to C.M. and C.G.; FWO fellowship 1.1A02.20N to S.B.), the KU Leuven (C1/18/006), and by gifts for the Hippo & Friends type 1 diabetes and Carpe Diem funds for diabetes research."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025